|
65677351212eaade2e0e1232
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018012330D
|
76_42192
|
1
|
Pakistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.49996
|
0.49996
|
0
|
0
|
0.49996
|
0.49996
|
0
|
0.49996
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677351212eaade2e0e1233
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018012330B
|
76_42192
|
1
|
Pakistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.38254
|
0.38254
|
0
|
0
|
0.38254
|
0.38254
|
0
|
0.38254
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677351212eaade2e0e1234
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018012330A
|
76_42192
|
1
|
Pakistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.6175
|
0.6175
|
0
|
0
|
0.6175
|
0.6175
|
0
|
0.6175
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677352212eaade2e0e1235
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018012330C
|
76_42192
|
1
|
Pakistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.3
|
0.3
|
0
|
0
|
0.3
|
0.3
|
0
|
0.3
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677352212eaade2e0e1236
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018012331
|
76_42192
|
3
|
Philippines
|
Far East Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.16837
|
0
|
0
|
0
|
0.16837
|
0
|
0
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677352212eaade2e0e1237
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018012332B
|
76_42192
|
3
|
Senegal
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.24127
|
0
|
0
|
0
|
0.24127
|
0
|
0
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677352212eaade2e0e1238
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018012332A
|
76_42192
|
1
|
Senegal
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.225
|
0.10246
|
0
|
0
|
0.225
|
0.10246
|
0
|
0.225
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677352212eaade2e0e1239
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018026041
|
76_60044
|
1
|
Senegal
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1.5
|
0
|
0
|
0
|
1.5
|
0
|
0
|
0
|
0
|
1.5
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of Medicines, Technol...ogies, and Pharmaceutical Services (MTaPS), a new activity, is to strengthen low- and middle-income country health systems to ensure sustainable access to, and appropriate use of, safe, effective, quality-assured, affordable essential medicines and medicines-related services. This will be accomplished by using a systems strengthening approach to technical assistance, customized based on country context, Mission objectives, and technical feasibility. In furtherance of this purpose, specific objectives that MTaPS will work to accomplish through technical assistance include: 1) Strengthening pharmaceutical sector governance; 2) Increasing institutional and human resource capacity for pharmaceutical management and services, including regulation of medical products; 3) Advancing the availability and use of pharmaceutical information for decision-making; 4) Optimized pharmaceutical sector financing, including resource allocation and use; and 5) Improved pharmaceutical services including product availability and patient-centered care to achieve desired health outcomes.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677352212eaade2e0e123a
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018012333
|
76_42192
|
1
|
Sierra Leone
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.1
|
0.02248
|
0
|
0
|
0.1
|
0.02248
|
0
|
0.1
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677352212eaade2e0e123b
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018026042
|
76_60044
|
1
|
Sierra Leone
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1.4
|
0
|
0
|
0
|
1.4
|
0
|
0
|
0
|
0
|
1.4
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of Medicines, Technol...ogies, and Pharmaceutical Services (MTaPS), a new activity, is to strengthen low- and middle-income country health systems to ensure sustainable access to, and appropriate use of, safe, effective, quality-assured, affordable essential medicines and medicines-related services. This will be accomplished by using a systems strengthening approach to technical assistance, customized based on country context, Mission objectives, and technical feasibility. In furtherance of this purpose, specific objectives that MTaPS will work to accomplish through technical assistance include: 1) Strengthening pharmaceutical sector governance; 2) Increasing institutional and human resource capacity for pharmaceutical management and services, including regulation of medical products; 3) Advancing the availability and use of pharmaceutical information for decision-making; 4) Optimized pharmaceutical sector financing, including resource allocation and use; and 5) Improved pharmaceutical services including product availability and patient-centered care to achieve desired health outcomes.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677352212eaade2e0e123c
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018012337B
|
76_42192
|
1
|
South of Sahara, regional
|
South of Sahara
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.1
|
0.1
|
0
|
0
|
0.1
|
0.1
|
0
|
0.1
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677352212eaade2e0e123d
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018012337A
|
76_42192
|
1
|
South of Sahara, regional
|
South of Sahara
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.13
|
0
|
0
|
0
|
0.13
|
0
|
0
|
0.13
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677352212eaade2e0e123e
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018012337C
|
76_42192
|
1
|
South of Sahara, regional
|
South of Sahara
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.243
|
0.12062
|
0
|
0
|
0.243
|
0.12062
|
0
|
0.243
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13040
|
STD control including HIV/AIDS
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677353212eaade2e0e123f
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018026048
|
76_60044
|
1
|
South of Sahara, regional
|
South of Sahara
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of Medicines, Technol...ogies, and Pharmaceutical Services (MTaPS), a new activity, is to strengthen low- and middle-income country health systems to ensure sustainable access to, and appropriate use of, safe, effective, quality-assured, affordable essential medicines and medicines-related services. This will be accomplished by using a systems strengthening approach to technical assistance, customized based on country context, Mission objectives, and technical feasibility. In furtherance of this purpose, specific objectives that MTaPS will work to accomplish through technical assistance include: 1) Strengthening pharmaceutical sector governance; 2) Increasing institutional and human resource capacity for pharmaceutical management and services, including regulation of medical products; 3) Advancing the availability and use of pharmaceutical information for decision-making; 4) Optimized pharmaceutical sector financing, including resource allocation and use; and 5) Improved pharmaceutical services including product availability and patient-centered care to achieve desired health outcomes.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677353212eaade2e0e1240
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018013276
|
76_46835
|
1
|
Syrian Arab Republic
|
Middle East
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.01282
|
0.01282
|
0
|
0
|
0.01282
|
0.01282
|
0
|
0.01282
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
SYSTEMS FOR IMPROVED ACCESS TO... PHARMACEUTICALS AND SERVICES (SIAPS)
more
|
Systems for Improved Access to... Pharmaceuticals and Services (SIAPS)
more
|
SIAPS focuses on enhancing pha...rmaceutical services through patientcentered solutions while continuing to support essential supply chain functions and medical products supply security. The SIAPS goal is to support the achievement of improved and sustained health outcomes by applying a systems strengthening approach consistent with the Global Health Initiative (GHI) principles. The SIAPS result areas address the intersections of five health systems components as they pertain to pharmaceutical services (governance, human resources, information, financing, and service delivery) in the design of potential interventions to ensure that they respond to health element and cross cutting concerns in support of health system strengthening.
more
|
From 2011 to 2018, the USAID-f...unded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program worked to ensure equitable, affordable access to safe, quality-assured medicines and related services in 46 countries throughout Africa, Asia, Europe, Latin America and the Caribbean, the Middle East, and Oceania.
The SIAPS pharmaceutical systems strengthening approach included local counterparts and partners in addressing five interrelated health system functions—governance, human resources, information, financing, and service delivery—with a focus on medicines.
The program tackled systemic deficiencies, going beyond the selection, procurement, and distribution of pharmaceutical products to include dispensing and supplying pharmaceuticals to individuals and providing medication-related information and counseling. Treatment focused on critical health areas, such as family planning, HIV/AIDS, malaria, maternal and child health, tuberculosis, and neglected tropical diseases and, more recently, Ebola.
more
|
72050
|
Relief co-ordination and suppo...rt services
more
|
|
VIII.1. Emergency Response
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677353212eaade2e0e1241
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018026044
|
76_60044
|
1
|
Tanzania
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
3
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
3
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of Medicines, Technol...ogies, and Pharmaceutical Services (MTaPS), a new activity, is to strengthen low- and middle-income country health systems to ensure sustainable access to, and appropriate use of, safe, effective, quality-assured, affordable essential medicines and medicines-related services. This will be accomplished by using a systems strengthening approach to technical assistance, customized based on country context, Mission objectives, and technical feasibility. In furtherance of this purpose, specific objectives that MTaPS will work to accomplish through technical assistance include: 1) Strengthening pharmaceutical sector governance; 2) Increasing institutional and human resource capacity for pharmaceutical management and services, including regulation of medical products; 3) Advancing the availability and use of pharmaceutical information for decision-making; 4) Optimized pharmaceutical sector financing, including resource allocation and use; and 5) Improved pharmaceutical services including product availability and patient-centered care to achieve desired health outcomes.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677353212eaade2e0e1242
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018026043
|
76_60044
|
1
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
2
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
2
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of Medicines, Technol...ogies, and Pharmaceutical Services (MTaPS), a new activity, is to strengthen low- and middle-income country health systems to ensure sustainable access to, and appropriate use of, safe, effective, quality-assured, affordable essential medicines and medicines-related services. This will be accomplished by using a systems strengthening approach to technical assistance, customized based on country context, Mission objectives, and technical feasibility. In furtherance of this purpose, specific objectives that MTaPS will work to accomplish through technical assistance include: 1) Strengthening pharmaceutical sector governance; 2) Increasing institutional and human resource capacity for pharmaceutical management and services, including regulation of medical products; 3) Advancing the availability and use of pharmaceutical information for decision-making; 4) Optimized pharmaceutical sector financing, including resource allocation and use; and 5) Improved pharmaceutical services including product availability and patient-centered care to achieve desired health outcomes.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677353212eaade2e0e1243
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018024673B
|
76_58282
|
3
|
Ukraine
|
Europe
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
1.7
|
0
|
0
|
0
|
1.7
|
0
|
0
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
SAFE, AFFORDABLE, AND EFFECTIV...E MEDICINES FOR UKRAINIANS (SAFEMED)
more
|
Safe, Affordable, and Effectiv...e Medicines for Ukrainians (SAFEMed)
more
|
SAFEMed will lead anti-corrupt...ion interventions in the pharmaceutical sector by building the country's capacity for transparent procurement of drugs and commodities and a sustainable national medicines selection process. The project will develop a procurement strategy to facilitate establishment of an efficient and cost-effective Central Procurement Body and will support adoption of evidence-based pharmaceutical laws, policies, regulations, and guidelines to address policy and legislative barriers. SAFEMed will support the Ministry of Health in the creation of the health technology assessment (HTA) agency as a legal entity for selection of effective and cost-effective medicines for procurement and reimbursement and will adopt and institutionalize best HTA practices. SAFEMed will also contribute to the creation of sustainable health pharmaceutical financing and advance rational pharmaceutical management and the supply chain system. The solutions will support decentralization and integration of health services across national and sub-national levels and secure a stable supply of essential HIV, medication-assisted treatment (MAT), TB, and Hepatitis C virus (HCV) drugs and commodities at their best prices in order to improve access to medicines and health services.
more
|
|
13040
|
STD control including HIV/AIDS
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677353212eaade2e0e1244
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018024673A
|
76_58282
|
1
|
Ukraine
|
Europe
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
2
|
1.53792
|
0
|
0
|
2
|
1.53792
|
0
|
2
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
SAFE, AFFORDABLE, AND EFFECTIV...E MEDICINES FOR UKRAINIANS (SAFEMED)
more
|
Safe, Affordable, and Effectiv...e Medicines for Ukrainians (SAFEMed)
more
|
SAFEMed will lead anti-corrupt...ion interventions in the pharmaceutical sector by building the country's capacity for transparent procurement of drugs and commodities and a sustainable national medicines selection process. The project will develop a procurement strategy to facilitate establishment of an efficient and cost-effective Central Procurement Body and will support adoption of evidence-based pharmaceutical laws, policies, regulations, and guidelines to address policy and legislative barriers. SAFEMed will support the Ministry of Health in the creation of the health technology assessment (HTA) agency as a legal entity for selection of effective and cost-effective medicines for procurement and reimbursement and will adopt and institutionalize best HTA practices. SAFEMed will also contribute to the creation of sustainable health pharmaceutical financing and advance rational pharmaceutical management and the supply chain system. The solutions will support decentralization and integration of health services across national and sub-national levels and secure a stable supply of essential HIV, medication-assisted treatment (MAT), TB, and Hepatitis C virus (HCV) drugs and commodities at their best prices in order to improve access to medicines and health services.
more
|
|
13040
|
STD control including HIV/AIDS
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677353212eaade2e0e1245
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018012335B
|
76_42192
|
3
|
Uzbekistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.46745
|
0
|
0
|
0
|
0.46745
|
0
|
0
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677353212eaade2e0e1246
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018012335A
|
76_42192
|
1
|
Uzbekistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.15
|
0.06831
|
0
|
0
|
0.15
|
0.06831
|
0
|
0.15
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677353212eaade2e0e1247
|
2018
|
United States
|
Agency for International Devel...opment
more
|
2018012321
|
76_42192
|
3
|
West Bank and Gaza Strip
|
Middle East
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.28749
|
0
|
0
|
0
|
0.28749
|
0
|
0
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677353212eaade2e0e1248
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009855D
|
76_42198
|
3
|
Bangladesh
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.185107
|
0
|
0
|
0
|
0.185107
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677353212eaade2e0e1249
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009855C
|
76_42198
|
3
|
Bangladesh
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.34518
|
0
|
0
|
0
|
0.34518
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677354212eaade2e0e124a
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009855B
|
76_42198
|
3
|
Bangladesh
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.220795
|
0
|
0
|
0
|
0.220795
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677354212eaade2e0e124b
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009855A
|
76_42198
|
3
|
Bangladesh
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.160916
|
0
|
0
|
0
|
0.160916
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677354212eaade2e0e124c
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022085D
|
76_60661
|
1
|
Bangladesh
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.537036
|
0.616718
|
0
|
0
|
0.537036
|
0.616718
|
0
|
|
|
0.537036
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
12110
|
Health policy and administrati...ve management
more
|
|
I.2.a. Health, General
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677354212eaade2e0e124d
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022085G
|
76_60661
|
1
|
Bangladesh
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.059804
|
0.059804
|
0
|
0
|
0.059804
|
0.059804
|
0
|
|
|
0.059804
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677354212eaade2e0e124e
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009857
|
76_42198
|
3
|
Benin
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.13
|
0
|
0
|
0
|
0.13
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677354212eaade2e0e124f
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009871
|
76_42198
|
3
|
Burkina Faso
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.066489
|
0
|
0
|
0
|
0.066489
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677354212eaade2e0e1250
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022101
|
76_60661
|
3
|
Burkina Faso
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.531723
|
0
|
0
|
0
|
0.531723
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677354212eaade2e0e1251
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022086
|
76_60661
|
3
|
Cameroon
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.584341
|
0
|
0
|
0
|
0.584341
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677354212eaade2e0e1252
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019024009
|
76_62926
|
1
|
Central Asia, regional
|
South & Central Asia
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.6075
|
0
|
0
|
0
|
0.6075
|
0
|
0
|
|
|
0.6075
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened; the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities; medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors; limited health resources must be generated, invested, and used efficiently; and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677354212eaade2e0e1253
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022089
|
76_60661
|
3
|
Côte d'Ivoire
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
1.25131
|
0
|
0
|
0
|
1.25131
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677355212eaade2e0e1254
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009873D
|
76_42198
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
1.01
|
0
|
0
|
0
|
1.01
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677355212eaade2e0e1255
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009873B
|
76_42198
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.516
|
0
|
0
|
0
|
0.516
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677355212eaade2e0e1256
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009873G
|
76_42198
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.060217
|
0
|
0
|
0
|
0.060217
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12240
|
Basic nutrition
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677355212eaade2e0e1257
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009873F
|
76_42198
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.104706
|
0
|
0
|
0
|
0.104706
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677355212eaade2e0e1258
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009873H
|
76_42198
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.894004
|
0
|
0
|
0
|
0.894004
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677355212eaade2e0e1259
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009873I
|
76_42198
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.2
|
0.349805
|
0
|
0
|
0.2
|
0.349805
|
0
|
0.2
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677355212eaade2e0e125a
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009873A
|
76_42198
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.055
|
0.523472
|
0
|
0
|
0.055
|
0.523472
|
0
|
0.055
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677355212eaade2e0e125b
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009873C
|
76_42198
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.46
|
0
|
0
|
0
|
0.46
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677355212eaade2e0e125c
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009873E
|
76_42198
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.25
|
0
|
0
|
0
|
0.25
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677355212eaade2e0e125d
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019022102C
|
76_60661
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.1
|
0.15
|
0
|
0
|
0.1
|
0.15
|
0
|
|
|
0.1
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
0
|
|
|
65677355212eaade2e0e125e
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019024008C
|
76_62926
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.05
|
0
|
0
|
0
|
0.05
|
0
|
0
|
|
|
0.05
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened; the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities; medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors; limited health resources must be generated, invested, and used efficiently; and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677356212eaade2e0e125f
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019024008D
|
76_62926
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.043554
|
0
|
0
|
0
|
0.043554
|
0
|
0
|
|
|
0.043554
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened; the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities; medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors; limited health resources must be generated, invested, and used efficiently; and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677356212eaade2e0e1260
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019024008E
|
76_62926
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1.35
|
0
|
0
|
0
|
1.35
|
0
|
0
|
|
|
1.35
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened; the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities; medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors; limited health resources must be generated, invested, and used efficiently; and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677356212eaade2e0e1261
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019024008B
|
76_62926
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.156446
|
0
|
0
|
0
|
0.156446
|
0
|
0
|
|
|
0.156446
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened; the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities; medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors; limited health resources must be generated, invested, and used efficiently; and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677356212eaade2e0e1262
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019024008A
|
76_62926
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.3
|
0
|
0
|
0
|
0.3
|
0
|
0
|
|
|
0.3
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened; the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities; medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors; limited health resources must be generated, invested, and used efficiently; and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
|
65677356212eaade2e0e1263
|
2019
|
United States
|
Agency for International Devel...opment
more
|
2019009858F
|
76_42198
|
3
|
Ethiopia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.07225
|
0
|
0
|
0
|
0.07225
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
United States Pharmacopeial Co...nvention
more
|
0
|
|
